Evidence map›Paper›PMID 34790819›Full record

ArticleBioMed research international2021

Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma.

Lian Zheng, Yang Yang, Xiaorong Cui

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Big Data in Gastroenterology Research.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lian ZhengDepartment of Gastroenterology, Third Affiliated Hospital (Jie'er Hospital), Chongqing Medical University, Chongqing, China.ORCID https://orcid.org/0000-0002-0448-1679
Yang YangDepartment of Geriatrics and Secret Service, First Affiliated Hospital, Army Medical University, Chongqing, China.
Xiaorong CuiDepartment of Geriatrics and Secret Service, First Affiliated Hospital, Army Medical University, Chongqing, China.ORCID https://orcid.org/0000-0001-8747-2788
Army Medical University · CNThird People 's Hospital of Chongqing · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAging is a process that biological changes accumulate with time and lead to increasing susceptibility to diseases like cancer. This study is aimed at establishing an aging-related prognostic signature in colon adenocarcinoma (COAD).

methodsThe transcriptome data and clinical variables of COAD patients were downloaded from TCGA database. The genes in GOBP_AGING gene set was used for prognostic evaluation by the univariate and multivariate Cox regression analyses. The model was presented by a nomogram and assessed by the Kaplan-Meier curves and calibration curves. The drug response and gene mutation were also performed to implicate the clinical significance. The GO and KEGG analyses were employed to unravel the potential functional mechanism.

resultsThe Gene Set Enrichment Analysis result indicates that GOBP_AGING pathway is significantly enriched in COAD samples. Four aging-related genes are finally used to construct the aging-related prognostic signature: FOXM1, PTH1R, KL, and CGAS. The COAD patients with high risk score have much shorter overall survival in both train cohort and test cohort. The nomogram is then assembled to predict 1-year, 3-year, and 5-year survival. Patients with high risk score have elevated infiltrating B cell naïve and attenuated cisplatin sensitivity. The mutation landscape shows that the TTN, FAT4, ZFHX4, APC, and OBSCN gene mutation are different between high risk score patients and low risk score patients. The differentially expressed genes between patients with high score and low score are enriched in B cell receptor signaling pathway.

conclusionWe constructed an aging-related signature in COAD patients, which can predict oncological outcome and optimize therapeutic strategy.

Indexed as

AdenocarcinomaAge FactorsBiomarkers, TumorColonic NeoplasmsDatabases, GeneticGene ExpressionGene Expression ProfilingHumansModels, TheoreticalMutationNomogramsPrognosisReproducibility of ResultsTranscriptomeBiomarkers, Tumor

Identifiers

PMID34790819
PMCPMC8592697
OpenAlexW3214661809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.